Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

Details for Australian Patent Application No. 2004238258 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Zhu, Lei; Lowe, Derek; Jenkins, Susan; Coish, Philip; Zhang, Mingbao; Smith, Roger; O'Connor, Stephen; Campbell, Ann-Marie; Wang, Gan; Su, Ning; Dai, Miao

Agent Davies Collison Cave

Pub. Number AU-A-2004238258

PCT Pub. Number WO2004/100881

Priority 60/469,619 09.05.03 US

Filing date 6 May 2004

Wipo publication date 25 November 2004

International Classifications

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4168 (2006.01)

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/100881 Priority application(s): WO2004/100881

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238259-System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram

2004238257-A method for altering insulin pharmacokinetics